These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28725248)

  • 1. Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region.
    Budrukkar A; Dasgupta A; Pandit P; Laskar SG; Murthy V; Upreti RR; Gupta T; Dholam K; Agarwal JP
    J Contemp Brachytherapy; 2017 Jun; 9(3):242-250. PubMed ID: 28725248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
    Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
    Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.
    Casey S; Awotwi-Pratt J; Bahl G
    Cureus; 2019 Dec; 11(12):e6412. PubMed ID: 31988814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review.
    Patro KC; Avinash A; Banidutta A; Kundu CR; Bhattacharya PS; Pilaka VKR; Muvvala M; Kumar AA; Aketi S; Karthikeyan K; Madasu BK; Vincent DT
    Radiat Oncol J; 2024 Jun; 42(2):154-159. PubMed ID: 38946078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface mould brachytherapy in oral and oropharyngeal cancers.
    Reshko LB; Gaskins JT; Bumpous JM; Tennant PA; Khan Z; Sowards K; Silverman CL; Dunlap NE
    Contemp Oncol (Pozn); 2021; 25(4):254-263. PubMed ID: 35079233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
    Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant soft tissue sarcoma of the shoulder treated by surface mould brachytherapy boost in an adjuvant setting.
    Mukherji A; Sinnatamby M
    J Contemp Brachytherapy; 2017 Apr; 9(2):167-173. PubMed ID: 28533807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
    Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
    Vavassori A; Riva G; Durante S; Fodor C; Comi S; Cambria R; Cattani F; Spadola G; Orecchia R; Jereczek-Fossa BA
    J Contemp Brachytherapy; 2019 Oct; 11(5):443-448. PubMed ID: 31749853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
    Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
    J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis and clinical outcomes in CT-based mould brachytherapy in early oral cancers in patients unfit for surgery.
    Mukherji A; Mourougan S; Saravannan K; Vivekanandam S; Reddy KS
    J Contemp Brachytherapy; 2015 Apr; 7(2):147-53. PubMed ID: 26034496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?
    Bartochowska A; Skowronek J; Wierzbicka M; Leszczynska M; Szyfter W
    Brachytherapy; 2015; 14(6):933-8. PubMed ID: 26249122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
    Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
    Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients - Gliwice experience.
    Kellas-Ślęczka S; Białas B; Fijałkowski M; Składowski K; Szlag M; Cholewka A
    J Contemp Brachytherapy; 2010 Jun; 2(2):61-63. PubMed ID: 27829846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
    Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
    Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual multi-catheter mould technique in high-dose-rate brachytherapy - personalized approach in treating multifocal angiosarcoma of the face.
    Szlag M; Wojcieszek P; Kellas-Ślęczka S; Krysiak K; Cholewka A; Stąpór-Fudzińska M; Krzysztofiak T; Fijałkowski M
    J Contemp Brachytherapy; 2019 Aug; 11(4):337-342. PubMed ID: 31523234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer.
    Pellizzon ACA; Fogaroli R; Chen MJ; Maia P; Gondim G; Guedes DC; Ramos H; Silva MLG
    J Contemp Brachytherapy; 2020 Oct; 12(5):435-440. PubMed ID: 33299432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.